Invention Grant
US07863298B2 Bridged ring structures as pharmaceutical agents 失效
桥接环结构作为药剂

Bridged ring structures as pharmaceutical agents
Abstract:
The present invention is directed to 1α,25-dihydroxyvitamin D3 mimics which modulate the vitamin D receptor (VDR). The invention is further directed to pharmaceutical compositions and methods for the treatment, prevention or amelioration of one or more symptoms of disease or disorder related to the activity of the vitamin D receptor using an effective amount of a compound of formula (I).
Public/Granted literature
Information query
Patent Agency Ranking
0/0